Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2000
06/07/2000EP1005549A2 Prostate tumor polynucleotide and antigen compositions
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005544A1 70 human secreted proteins
06/07/2000EP1005532A1 Isolated nucleic acid molecules encoding ssx family members and uses thereof
06/07/2000EP1005494A1 High avidity polyvalent and polyspecific reagents
06/07/2000EP1005489A1 Novel polypeptides within the growth factor superfamily
06/07/2000EP1005488A1 Receptor that binds trail
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases
06/07/2000EP1005371A2 Method and food product for increasing muscle protein and reducing fat in animals
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005363A2 Recombinant dimeric envelope vaccine against flaviviral infection
06/07/2000EP1005360A1 Antioxidant protein 2, gene and methods of use therefor
06/07/2000EP0950189A4 Brca1 associated protein (bap-1) and uses therefor
06/07/2000EP0636171B1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse malignant cells
06/07/2000CN1255862A Use of avian antibodies
06/07/2000CN1255860A Immunogenic compsns to CCK-b/gastrin-receptor and methods for treatment of tumors
06/07/2000CN1255858A Cachevia remedy
06/07/2000CN1255378A Monoclonal antibody Fab'-Pingyangmycin conjugate and its anticancer action
06/06/2000US6072048 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
06/06/2000US6072047 Nucleotide and amino acid sequence that binds the protein known as tumor necrosis factor-related apoptosis-inducing ligand; for recombinant expression; for purifying protein or suppressing activities
06/06/2000US6072045 Chimeric isoprenoid synthases and uses thereof
06/06/2000US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell
06/06/2000US6072037 Antibodies to the IL-17 receptor
06/06/2000US6072036 Antibody containing a secretory signal and an intracellular retention sequence; for genetically engineered expression inside cells; for antitumor/anticarcinogenic agents and viricides
06/06/2000US6072035 Reshaped monoclonal antibodies against an immunoglobulin isotype
06/06/2000US6072033 Receptor that binds IL-17
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6072031 Amino acid sequences of human protein; for diagnosis of cancer and anticarcinogenic agents
06/06/2000US6072028 Amino acid sequence of effector cell protease receptor-1, a transmembrane glycoprotein receptor for factor xa; immunosuppressants for autoimmune disorders; suppression or activation of lymphocyte proliferation; diagnosis of disease
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein
06/06/2000US6071879 Method for the treatment of bacterial infection
06/06/2000US6071877 Polypeptides having a toxic activity against insects of the dipterae family
06/06/2000US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins
06/06/2000US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
06/06/2000US6071737 Equine Neospora isolate and its uses
06/06/2000US6071736 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
06/06/2000US6071732 Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof
06/06/2000US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071721 Calcium binding protein
06/06/2000US6071720 Polynucleotide coding a polypeptide associated with ionic mobility; for the diagnosis, treatment or prevention of nervous system disorders, cardiovascular disorders and cancer; anticarcinogenic agents
06/06/2000US6071719 Polynucleotide sequence coding a membrane protein; for the treatment and prevention of infections
06/06/2000US6071715 Nucleic acids encoding novel proteins which bind to retinoblastoma protein
06/06/2000US6071709 Nerve growth factor/receptor complex
06/06/2000US6071708 Morphogenic protein compositions of matter
06/06/2000US6071707 Phosphotyrosine mimics and method for identifying and using same
06/06/2000US6071706 Stabilising medium for alphagst in urine for use in an enzyme immunoassay
06/06/2000US6071705 Method of detecting neurological disease or dysfunction
06/06/2000US6071701 Detecting polynucleotide sequences which code polypeptide associated with inflammation; contacting nucleic acids with a polynucleotide sequence which codes inflammation polypeptide, allowing hybridization, detecting hybridization products
06/06/2000US6071697 Method for testing the differentiation status in pancreatic cells of a mammal
06/06/2000US6071518 GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium
06/06/2000US6071517 Induction of effector-cell-mediated cytolysis; antitumor agents
06/06/2000US6071516 Administering normal gamma-globulin
06/06/2000US6071515 Dimer and multimer forms of single chain polypeptides
06/06/2000US6071491 Administering an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled
06/06/2000CA2057896C Biologically active polypeptides based on transformed growth factor-beta sequences
06/06/2000CA1341020C Lipoprotein i (ompi) of pseudomonas aeruginosa
06/06/2000CA1341018C Immunotoxins based on inactivated diphtheria toxins for cancer chemotherapy
06/06/2000CA1341015C Outer membrane protein f of pseudomonas aeruginosa
06/06/2000CA1341014C Hcg peptides for use in antibody purification procedures
06/02/2000WO2000031546A1 Antibodies to peptides that target git receptors and related methods
06/02/2000WO2000031533A1 Test kit and method of diagnosing severe acute pancreatitis
06/02/2000WO2000031278A1 Zace1: a human metalloenzyme
06/02/2000WO2000031270A1 Bartonella proteins and uses thereof
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031253A2 Mutation of the parkin gene, compositions, methods and uses
06/02/2000WO2000031252A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
06/02/2000WO2000031248A1 Humanized monoclonal antibodies
06/02/2000WO2000031141A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof
06/02/2000WO2000031138A1 Membrane antigenic structure inducing stoppage of proliferation and apoptosis of activated t-lymphocytes
06/02/2000WO2000031133A2 Potassium channel interactors and uses therefor
06/02/2000WO2000031127A2 Protein fragments for use in protein targeting
06/02/2000WO2000031126A2 Suppression of xenotransplant rejection
06/02/2000WO2000031125A2 REGULATORY PROTEIN pKe#83 FROM HUMAN KERATINOCYTES
06/02/2000WO2000031123A2 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
06/02/2000WO2000031115A1 Methods of identifying antigen gene sequences
06/02/2000WO2000031108A1 Dna molecules encoding hg51, a g-protein-coupled receptor
06/02/2000WO2000030681A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
06/02/2000WO2000030680A1 Tumor antigen-specific antibody-gp39 chimeric protein constructs
06/02/2000WO2000030679A1 Cd25 binding molecules for use in the treatment of manifestations of rejection in transplantation
06/02/2000WO2000030673A1 Uses for eph receptor antagonists and agonists to treat vascular disorders
06/02/2000WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000WO2000030425A2 Method of using pon-1 to decrease atheroma formation
06/02/2000WO2000014545A9 Multihued labels
06/02/2000WO2000014542A3 Diagnostic method for detecting disturbances of the pancreas
06/02/2000WO2000012545A3 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
06/02/2000WO2000009715A9 Modulation of polypeptide display on modified filamentous phage
06/02/2000WO2000008177A3 Death associated kinase containing ankyrin repeats (dakar)
06/02/2000WO2000006203A9 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis
06/02/2000WO2000005389A3 Production of proteins
06/02/2000WO2000003024A9 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon
06/02/2000WO1999064594A8 Genes and gene expression products that are differentially regulated in prostate cancer
06/02/2000WO1999063095A9 Nucleic acid vaccines for prevention of flavivirus infection
06/02/2000WO1999062942A3 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
06/02/2000WO1999054446A3 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
06/02/2000CA2352963A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
06/02/2000CA2352599A1 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000CA2352495A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target